POTS Subtypes Explained
Neuropathic, hyperadrenergic, hypovolemic — POTS isn't one disease. Identifying the dominant mechanism shapes the treatment plan.
You do not need a referral from your doctor. Request an appointment online in about two minutes, and we will call you to arrange a time. Testing takes 40–60 minutes.
Request an appointment →Please note the tests themselves are not covered by a Medicare rebate. Questions? Call 02 9388 0615.
POTS Is a Syndrome, Not a Single Disease
Postural Orthostatic Tachycardia Syndrome — POTS — describes a pattern: sustained heart rate rise of ≥30 bpm (40 bpm in adolescents) on standing, without significant blood pressure drop, in association with symptoms. But the underlying mechanisms that produce that pattern differ from patient to patient. Three main subtypes are recognised, and many patients have features of more than one.
Why does subtyping matter? Because it changes treatment. Hyperadrenergic patients often respond best to medications that blunt sympathetic outflow (beta-blockers, clonidine). Neuropathic POTS may respond to volume-targeted strategies, midodrine, or in selected cases immunotherapy. Hypovolemic POTS responds particularly well to fluid expansion, fludrocortisone, and salt loading. Getting the mechanism right reduces trial-and-error.
The Three Main Subtypes
Neuropathic POTS≈ 30–50% of cases
Caused by a partial autonomic neuropathy — typically affecting the small unmyelinated nerve fibres responsible for vasoconstriction in the lower limbs. When standing, these fibres normally constrict leg veins to push blood back up to the heart. When they don't, blood pools in the legs, venous return drops, and the heart compensates with tachycardia.
Key features
Reduced sweating in the feet on SudoScan or QSART. Symptoms of small fibre neuropathy (burning feet, patchy numbness). Often follows viral illness, surgery, or pregnancy.
Often associated with
Diabetes, autoimmune disease, Sjögren's syndrome, post-viral (including post-COVID), idiopathic small fibre neuropathy.
Typical treatment direction
Volume support (fluids, salt, compression). Midodrine to enhance peripheral vasoconstriction. Pyridostigmine. In selected cases, immunotherapy where autoimmune mechanism is established.
Hyperadrenergic POTS≈ 30–60% of cases
Excessive sympathetic outflow on standing — high circulating norepinephrine, with classical "fight-or-flight" symptoms accompanying the tachycardia. Patients often report tremor, sweating, anxiety, palpitations, and migraine-like headaches. Standing norepinephrine is typically ≥600 pg/mL (vs <300 normal). Some hyperadrenergic POTS is secondary to mast cell activation, anxiety, baroreflex dysfunction, or norepinephrine transporter deficiency.
Key features
Tremor, sweating, hypertensive episodes, anxiety, migraine, sometimes flushing. Standing BP may actually rise rather than fall. Often more disabling cognitive symptoms.
Often associated with
Mast cell activation syndrome (MCAS), anxiety disorders, post-traumatic stress, baroreflex failure, norepinephrine transporter deficiency.
Typical treatment direction
Beta-blockers (propranolol, ivabradine for HR control). Clonidine or guanfacine for central sympathetic blockade. Methyldopa. Treatment of comorbid MCAS or anxiety where present.
Hypovolemic POTSoverlap with above
Low circulating blood volume — sometimes by 10–30% below normal — leading to inadequate venous return on standing. The reduced volume is partly explained by reduced renin/aldosterone activity. May coexist with neuropathic or hyperadrenergic features.
Key features
Marked symptom improvement with fluid loading or IV saline. Often dry skin, low urine output, postural symptoms worse first thing in the morning.
Often associated with
Deconditioning, prolonged bedrest, hyperadrenergic POTS (paradox: high NE may suppress renin).
Typical treatment direction
Aggressive fluid expansion. High salt intake (often 8–10 g/day). Fludrocortisone. Compression. Recumbent exercise.
Overlap Is the Rule, Not the Exception
In real-world practice, very few patients fit cleanly into a single subtype. Most have features of two or all three. About half also have evidence of small fibre neuropathy on objective testing — even patients who present as predominantly hyperadrenergic. Around 30% have features of mast cell activation. Many have hypermobile Ehlers-Danlos syndrome (hEDS) on top.
The practical implication: treatment is rarely "one drug for one subtype". Most patients end up on a combination — fluids, salt, compression, recumbent exercise (universal foundation) plus medication selected for their dominant mechanism, adjusted over time as response is assessed.
Read more about overlap conditions on our POTS overlap page.
Comparing the Three Subtypes
| Feature | Neuropathic | Hyperadrenergic | Hypovolemic |
|---|---|---|---|
| Standing HR rise | ≥30 bpm | ≥30 bpm (often higher) | ≥30 bpm |
| Standing BP | Stable or slight drop | May rise | Stable or slight drop |
| Standing NE | Variable | ≥600 pg/mL | Variable |
| Hallmark symptoms | Burning feet, postural lightheadedness, blood pooling | Tremor, sweating, anxiety, migraine | Marked thirst, low volume, BP-fluid sensitivity |
| SudoScan / QSART | Often abnormal | Often normal | Variable |
| First-line medication | Midodrine, pyridostigmine | Beta-blocker, ivabradine, clonidine | Fludrocortisone, IV saline |
| Common comorbidity | Small fibre neuropathy, autoimmune | MCAS, anxiety, baroreflex | Deconditioning |
How We Identify the Subtype
Autonomic testing protocol
A comprehensive autonomic battery — active stand test with recovery blood pressure + heart rate variability + Valsalva + isometric handgrip + SudoScan — gives the mechanistic information needed to identify the dominant subtype. Standing plasma norepinephrine adds further detail for suspected hyperadrenergic POTS. The full battery is completed in a single visit. More about test methods →
Get Tested. Get Your Subtype Identified.
Comprehensive autonomic testing in a single visit. Results and report within a week.
Book POTS TestingBook Your POTS Test Today
Stop waiting years for answers. Fill out the form below and we'll contact you to schedule your appointment. Get tested and receive your results within one week.
Thank you for getting in touch!
One of our colleagues will get back to you shortly.
Have a great day!